Ruxolitinib During Stem Cell Transplant
Peri-Hematopoietic Cell Transplantation Ruxolitinib in Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 50 patients (estimated)
- Tags
- Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2229
- NCT Identifier
- NCT07228624
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.